StockWatch
·
Biotechnology: Pharmaceutical Preparations
Management ChangeAug 7, 2026, 04:19 PM

Biohaven Appoints John Yetimoglu to Board of Directors

AI Summary

Biohaven Ltd. announced the appointment of John Yetimoglu to its Board of Directors, effective August 6, 2026. Mr. Yetimoglu will also join the Nominating and Governance Committee. As part of his compensation, he will receive options valued at $713,875 and an annual retainer of $57,000.

Key Highlights

  • Biohaven Ltd. appointed John Yetimoglu as a director, effective August 6, 2026.
  • Mr. Yetimoglu will serve until the Company's 2027 Annual Meeting of Shareholders.
  • He was also appointed as a member of the Nominating and Governance Committee.
  • Mr. Yetimoglu will receive options to purchase common shares with a grant date fair value of $713,875.
  • The options will vest 25% on grant and 25% on each of the following three anniversaries.
  • He will also receive a $57,000 annual retainer for his service as a director and committee member.